J&J to start human testing of coronavirus vaccine by September

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG2T13K_L.jpg

J&J also committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority (BARDA) to co-fund vaccine research, expanding a previous collaboration.

Global efforts are underway to develop a vaccine for the virus that has killed over 34,000 worldwide, but experts have cautioned it could take over a year to have a vaccine ready.

A patient was dosed with Moderna Inc’s (O:MRNA) vaccine in an early-stage trial earlier this month, making it the front-runner in the race to develop a viable vaccine.

J&J said in January it had begun working on a possible vaccine for the coronavirus, using the same technologies used to make its experimental Ebola vaccine.